Trials / Terminated
TerminatedNCT01907191
Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy
Comparison of Bupivacaine to Liposomal Bupivacaine for Ultrasound Guided Periarticular Hip Infiltration for Postoperative Analgesia After Hip Arthroscopy.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Trinity Health Of New England · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while regular bupivacaine can provide pain relief up to 12 hours
Detailed description
Patients undergoing hip arthroscopy experience moderate to severe postoperative pain. Effective pain control after surgery is an important component in the overall management of these patients. Good pain control encourages early participation in rehabilitation program, increases success of the surgery, and improves patient satisfaction. Typically, postoperative analgesia is provided to these patients either with nerve blocks or opioid medications. Both these methods provide good pain relief but nerve blocks are associated with weakness of lower extremity muscles which interferes with early ambulation and increase the risk of falls while narcotic medications increase the risk of nausea, vomiting, itching, constipation, ileus, urinary retention, sedation and respiratory depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | liposomal bupivacaine | (Ultrasound guided injection of liposomal bupivacaine) for patients undergoing hip arthroscopy |
| DRUG | Bupivacaine | (around the anterior, lateral and medial aspect of hip joint) for patients undergoing hip arthroscopy |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2019-01-30
- Completion
- 2019-01-30
- First posted
- 2013-07-24
- Last updated
- 2022-08-16
- Results posted
- 2022-07-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01907191. Inclusion in this directory is not an endorsement.